W. Kisiel, C. A. Sprecher, and D. C. Foster, Evidence that a second human tissue factor pathway inhibitor (TFPI-2) and human placental protein 5 are equivalent, Blood, vol.84, pp.4384-4389, 1994.

R. Butzow, M. L. Huhtala, H. Bohn, I. Virtanen, and M. Seppala, Purification and characterization of placental protein 5, Biochem Biophys Res Commun, vol.150, pp.483-90, 1988.

C. N. Rao, C. L. Peavey, Y. Y. Liu, J. C. Lapiere, and D. T. Woodley, Partial characterization of matrixassociated serine protease inhibitors from human skin cells, J Invest Dermatol, vol.104, pp.379-83, 1995.

C. N. Rao, P. Reddy, Y. Liu, E. O'toole, D. Reeder et al., Extracellular matrix-associated serine protease inhibitors (Mr 33,000, 31,000, and 27,000) are single-gene products with differential glycosylation: cDNA cloning of the 33-kDa inhibitor reveals its identity to tissue factor pathway inhibitor-2, Arch Biochem Biophys, vol.335, pp.82-92, 1996.

R. Butzow, H. Alfthan, U. H. Stenman, A. M. Suikkari, H. Bohn et al., Immunofluorometric demonstration and quantification of placental protein 5 in the absence of pregnancy, Clin Chem, vol.34, pp.1591-1594, 1988.

M. Seppala, T. Wahlstrom, and H. Bohn, Circulating levels and tissue localization of placental protein five (PP5) in pregnancy and trophoblastic disease: absence of PP5 expression in the malignant trophoblast, Int J Cancer, vol.24, pp.6-10, 1979.

J. E. Siiteri, R. Koistinen, H. T. Salem, H. Bohn, and M. Seppala, Placental protein 5 is related to blood coagulation and fibrinolytic systems, Life Sci, vol.30, pp.1885-91, 1982.

K. Udagawa, Y. Miyagi, F. Hirahara, E. Miyagi, Y. Nagashima et al., Specific expression of PP5/TFPI2 mRNA by syncytiotrophoblasts in human placenta as revealed by in situ hybridization, Placenta, vol.19, pp.217-240, 1998.

R. Butzow, I. Virtanen, M. Seppala, O. Narvanen, U. H. Stenman et al., Monoclonal antibodies reacting with placental protein 5: use in radioimmunoassay, Western blot analysis, and immunohistochemistry, J Lab Clin Med, vol.111, pp.249-56, 1988.

K. Udagawa, H. Yasumitsu, M. Esaki, H. Sawada, Y. Nagashima et al., Subcellular localization of PP5/TFPI-2 in human placenta: a possible role of PP5/TFPI-2 as an anti-coagulant on the surface of syncytiotrophoblasts, Placenta, vol.23, pp.145-53, 2002.

F. Hubé, P. Reverdiau, S. Iochmann, S. Trassard, G. Thibault et al., Demonstration of a tissue factor pathway inhibitor-2 messenger RNA synthesis by pure villous cytotrophoblast cells isolated from term human placentas, Biol Reprod, vol.68, pp.1888-94, 2003.

Y. Miyagi, N. Koshikawa, H. Yasumitsu, E. Miyagi, F. Hirahara et al., cDNA cloning and mRNA expression of a serine proteinase inhibitor secreted by cancer cells: identification as placental protein 5 and tissue factor pathway inhibitor-2, J Biochem, vol.116, pp.939-981, 1994.

E. Sierko, M. Z. Wojtukiewicz, L. Zimnoch, L. Kozlowski, S. Sulkowski et al., Immunohistochemical localization of tissue factor pathway inhibitor-2 in human tumor tissue, Blood, vol.100, p.486, 2002.

Y. Miyagi, H. Yasumitsu, H. Mizushima, N. Koshikawa, Y. Matsuda et al., Cloning of the cDNA encoding mouse PP5/TFPI-2 and mapping of the gene to chromosome 6, DNA Cell Biol, vol.15, pp.947-54, 1996.

C. N. Rao, Y. Y. Liu, C. L. Peavey, and D. T. Woodley, Novel extracellular matrix-associated serine proteinase inhibitors from human skin fibroblasts, Arch Biochem Biophys, vol.317, pp.311-315, 1995.

M. Iino, D. C. Foster, and W. Kisiel, Quantification and characterization of human endothelial cell-derived tissue factor pathway inhibitor-2, Arterioscler Thromb Vasc Biol, vol.18, pp.40-46, 1998.

H. Izumi, C. Takahashi, J. Oh, and M. Noda, Tissue factor pathway inhibitor-2 suppresses the production of active matrix metalloproteinase-2 and is down-regulated in cells harboring activated ras oncogenes, Febs Lett, vol.481, pp.31-37, 2000.

J. Ortego, J. Escribano, and M. Coca-prados, Gene expression of proteases and protease inhibitors in the human ciliary epithelium and ODM-2 cells, Exp Eye Res, vol.65, pp.289-99, 1997.

F. M. Deng, M. Ding, R. M. Lavker, and T. T. Sun, Urothelial function reconsidered: a role in urinary protein secretion, Proc Natl Acad Sci, vol.98, pp.154-163, 2001.

R. Blindt, F. Vogt, D. Lamby, U. Zeiffer, N. Krott et al.,

J. Dahl and A. K. Bosserhoff, Characterization of differential gene expression in quiescent and invasive human arterial smooth muscle cells, J Vasc Res, vol.39, pp.340-52, 2002.

J. T. Crawley, D. A. Goulding, V. Ferreira, N. J. Severs, and F. Lupu, Expression and localization of tissue factor pathway inhibitor-2 in normal and atherosclerotic human vessels, Arterioscler Thromb Vasc Biol, vol.22, pp.218-242, 2002.

P. Reverdiau-moalic, S. Iochmann, E. Rideau, G. Thibault, P. Bardos et al., Simultaneous expression of tissue factor, tissue factor pathway inhibitor 1 and 2 in blood monocytesderived macrophages, Circulation, vol.98, p.525, 1998.

C. N. Rao, S. Mohanam, A. Puppala, and J. S. Rao, Regulation of ProMMP-1 and ProMMP-3 activation by tissue factor pathway inhibitor-2/matrix-associated serine protease inhibitor, Biochem Biophys Res Commun, vol.255, pp.94-102, 1999.

Y. Liu, S. M. Stack, S. S. Lakka, A. J. Khan, D. T. Woodley et al., Matrix localization of tissue factor pathway inhibitor-2/matrix-associated serine protease inhibitor (TFPI-2/MSPI) involves arginine-mediated ionic interactions with heparin and dermatan sulfate: heparin accelerates the activity of TFPI-2/MSPI toward plasmin, Arch Biochem Biophys, vol.370, pp.112-120, 1999.

C. N. Rao, P. Reddy, D. J. Reeder, Y. Liu, S. M. Stack et al., Prokaryotic expression, purification, and reconstitution of biological activities (Antiprotease, antitumor, and heparin-binding) for tissue factor pathway inhibitor-2, Biochem Biophys Res Commun, vol.276, pp.1286-94, 2000.

A. J. Horrevoets, R. D. Fontijn, A. J. Van-zonneveld, C. J. De-vries, J. W. Cate et al., Vascular endothelial genes that are responsive to tumor necrosis factor-alpha in vitro are expressed in atherosclerotic lesions, including inhibitor of apoptosis protein-1, stannin, and two novel genes, Blood, vol.93, pp.3418-3449, 1999.

M. P. Herman, G. K. Sukhova, W. Kisiel, D. Foster, M. R. Kehry et al., Tissue factor pathway inhibitor-2 is a novel inhibitor of matrix metalloproteinases with implications for atherosclerosis, J Clin Invest, vol.107, pp.1117-1143, 2001.

S. Iochmann, P. Reverdiau-moalic, F. Hubé, P. Bardos, and Y. Gruel, Demonstration of inducible TFPI-2 mRNA synthesis in BeWo and JEG-3 trophoblast cells using a competitive RT-PCR, Thromb Res, vol.105, pp.217-240, 2002.
URL : https://hal.archives-ouvertes.fr/hal-02127753

H. Zhu, J. P. Cong, G. Mamtora, T. Gingeras, and T. Shenk, Cellular gene expression altered by human cytomegalovirus: global monitoring with oligonucleotide arrays, Proc Natl Acad Sci, vol.95, pp.14470-14475, 1998.

C. E. Schwartz, P. Stanislovitis, M. C. Phelan, K. Klinger, H. A. Taylor et al., Deletion mapping of plasminogen activator inhibitor, type I (PLANH1) and beta-glucuronidase (GUSB) in 7q21-q22, Cytogenet Cell Genet, vol.56, pp.152-155, 1991.

C. A. Sprecher, W. Kisiel, S. Mathewes, and D. C. Foster, Molecular cloning, expression, and partial characterization of a second human tissue-factor-pathway inhibitor, Proc Natl Acad Sci, vol.91, pp.3353-3360, 1994.

S. Kamei, Y. Kazama, J. L. Kuijper, D. C. Foster, and W. Kisiel, Genomic structure and promoter activity of the human tissue factor pathway inhibitor-2 gene, Biochim Biophys Acta, vol.1517, pp.430-435, 2001.

F. Hubé, P. Reverdiau, S. Iochmann, C. Cherpi-antar, and Y. Gruel, Characterization and functional analysis of TFPI-2 gene promoter in a human choriocarcinoma cell line, Thromb Res, vol.109, pp.207-222, 2003.

S. D. Konduri, F. A. Osman, C. N. Rao, H. Srinivas, N. Yanamandra et al., Minimal and inducible regulation of tissue factor pathway inhibitor-2 in human gliomas, Oncogene, vol.21, pp.921-929, 2002.

C. Kast, M. Wang, and M. Whiteway, The ERK/MAPK pathway regulates the activity of the human tissue factor pathway inhibitor-2 promoter, J Biol Chem, vol.278, pp.6787-94, 2003.

S. Wolter, J. F. Mushinski, A. M. Saboori, K. Resch, and M. Kracht, Inducible expression of a constitutively active mutant of mitogen-activated protein kinase kinase 7 specifically activates c-JUN NH2-terminal protein kinase, alters expression of at least nine genes, and inhibits cell proliferation, J Biol Chem, vol.277, pp.3576-84, 2002.

M. Hinz, P. Lemke, I. Anagnostopoulos, C. Hacker, D. Krappmann et al., Nuclear factor kappaB-dependent gene expression profiling of Hodgkin's disease tumor cells, pathogenetic significance, and link to constitutive signal transducer and activator of transcription 5a activity, J Exp Med, vol.196, pp.605-622, 2002.

Y. Kazama, S. Kamei, J. L. Kuijper, D. C. Foster, and W. Kisiel, Nucleotide sequence of the gene encoding murine tissue factor pathway inhibitor-2, Thromb Haemost, vol.83, pp.141-148, 2000.

F. Hubé, P. Reverdiau, S. Iochmann, J. Rollin, C. Cherpi-antar et al., Transcriptional silencing of TFPI-2 gene by hypermethylation of the promoter in choriocarcinoma cells, Biol Chem, vol.384, pp.1029-1063, 2003.

C. N. Rao, T. Segawa, J. R. Navari, L. Xu, S. Srivastava et al., Methylation of TFPI-2 gene is not the sole cause of its silencing, Int J Oncol, vol.22, pp.843-851, 2003.

T. Hisaka, W. Kisiel, and J. Rosenbaum, cDNA cloning and tissue distribution of the rat ortholog of tissue factor pathway inhibitor-2, Thromb Haemost, vol.88, pp.356-363, 2002.

L. C. Petersen, C. A. Sprecher, D. C. Foster, H. Blumberg, T. Hamamoto et al., Inhibitory properties of a novel human Kunitz-type protease inhibitor homologous to tissue factor pathway inhibitor, Biochemistry, vol.35, pp.266-72, 1996.

S. Kamei, L. C. Petersen, C. A. Sprecher, D. C. Foster, and W. Kisiel, Inhibitory properties of human recombinant Arg24-> Gln type-2 tissue factor pathway inhibitor (R24Q TFPI-2), Thromb Res, vol.94, pp.147-52, 1999.

F. Hubé, P. Reverdiau, S. Iochmann, and Y. Gruel, 3D modeling of human TFPI-2 kunitz-type protease inhibitor complexed with human plasmin, Thromb Res, vol.111, pp.197-205, 2003.

Y. Miyagi, H. Yasumitsu, T. Eki, S. Miyata, N. Kkawa et al., Assignment of the human PP5/TFPI-2 gene to 7q22 by FISH and PCR-based human/rodent cell hybrid mapping panel analysis, Genomics, vol.35, pp.267-275, 1996.

Y. Kazama, M. Souri, W. Kisiel, and J. Degen, Tissue factor pathway inhibitor-2 (TFPI-2) deficiency is compatible with development, growth to adulthood, and fertility. Résumé de l, Blood, vol.100, p.486, 2002.

C. N. Rao, S. S. Lakka, Y. Kin, S. D. Konduri, G. N. Fuller et al., Expression of tissue factor pathway inhibitor 2 inversely correlates during the progression of human gliomas, Clin Cancer Res, vol.7, pp.570-576, 2001.

S. S. Lakka, S. D. Konduri, S. Mohanam, G. L. Nicolson, and J. S. Rao, In vitro modulation of human lung cancer cell line invasiveness by antisense cDNA of tissue factor pathway inhibitor-2, Clin Exp Metastasis, vol.18, pp.239-283, 2000.

V. Neaud, T. Hisaka, A. Monvoisin, C. Bedin, C. Balabaud et al., Paradoxical pro-invasive effect of the serine proteinase inhibitor tissue factor pathway inhibitor-2 on human hepatocellular carcinoma cells, J Biol Chem, vol.275, pp.35565-35574, 2000.

C. N. Rao, B. Cook, Y. Liu, K. Chilukuri, M. S. Stack et al., HT-1080 fibrosarcoma cell matrix degradation and invasion are inhibited by the matrix-associated serine protease inhibitor TFPI-2/33 kDa MSPI, Int J Cancer, vol.76, pp.749-56, 1998.

S. D. Konduri, A. Tasiou, N. Chandrasekar, and J. S. Rao, Overexpression of tissue factor pathway inhibitor-2 (TFPI-2), decreases the invasiveness of prostate cancer cells in vitro, Int J Oncol, vol.18, pp.127-158, 2001.

S. D. Konduri, A. Tasiou, N. Chandrasekar, G. L. Nicolson, and J. S. Rao, Role of tissue factor pathway inhibitor-2 (TFPI-2) in amelanotic melanoma (C-32) invasion, Clin Exp Metastasis, vol.18, pp.303-311, 2000.

M. Jin, K. Udagawa, E. Miyagi, T. Nakazawa, F. Hirahara et al., Expression of serine proteinase inhibitor PP5/TFPI-2/MSPI decreases the invasive potential of human choriocarcinoma cells in vitro and in vivo, Gynecol Oncol, vol.83, pp.325-358, 2001.

E. G. Fischer, M. Riewald, H. Y. Huang, Y. Miyagi, Y. Kubota et al., Tumor cell adhesion and migration supported by interaction of a receptor-protease complex with its inhibitor, J Clin Invest, vol.104, pp.1213-1234, 1999.

N. B. Atkin and M. C. Baker, Chromosome 7q deletions : observations on 13 malignant tumors, Cancer Genet Cytogenet, vol.67, pp.123-128, 1993.

A. Tasiou, S. D. Konduri, N. Yanamandra, D. H. Dinh, W. C. Olivero et al., A novel role of tissue factor pathway inhibitor-2 in apoptosis of malignant human gliomas, Int J Oncol, vol.19, pp.591-598, 2001.

E. Shinoda, Y. Yui, R. Hattori, M. Tanaka, R. Inoue et al., Tissue factor pathway inhibitor-2 is a novel mitogen for vascular smooth muscle cells, J Biol Chem, vol.274, pp.5379-84, 1999.

B. Welm, J. Mott, and Z. Werb, Developmental biology: vasculogenesis is a wreck without RECK, Curr Biol, vol.12, pp.209-220, 2002.

A. H. Baker, D. R. Edwards, and G. Murphy, Metalloproteinase inhibitors: biological actions and therapeutic opportunities, J Cell Sci, vol.115, pp.3719-3746, 2002.